The World Health Organisation 2021 Classification of Tumors of the Central Nervous System underscores the importance of IDH mutation and 1p/19q codeletion in glioma subtyping [228], as these genomic alterations are often associated with specific imaging patterns. The gene discussed is IDH1; the disease is central nervous system cancer.